C7ORF25 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.800200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.879800E-01
Normal-vs-Stage2
6.196800E-01
Normal-vs-Stage3
5.435800E-01
Normal-vs-Stage4
4.810800E-01
Stage1-vs-Stage2
8.892300E-02
Stage1-vs-Stage3
1.396600E-01
Stage1-vs-Stage4
7.008200E-01
Stage2-vs-Stage3
4.961200E-01
Stage2-vs-Stage4
7.168200E-02
Stage3-vs-Stage4
1.996220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.384200E-01
Normal-vs-AfricanAmerican
7.007400E-01
Normal-vs-Asian
8.623600E-01
Caucasian-vs-AfricanAmerican
9.731200E-01
Caucasian-vs-Asian
8.767800E-01
AfricanAmerican-vs-Asian
9.124200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.217200E-01
Normal-vs-Female
9.961400E-01
Male-vs-Female
5.449800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.573000E-01
Normal-vs-Age(41-60Yrs)
7.868200E-01
Normal-vs-Age(61-80Yrs)
6.155600E-01
Normal-vs-Age(81-100Yrs)
5.380000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.516600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.412000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.543200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.777800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.077370E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.309000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.506200E-01
Normal-vs-Daily Drinker
2.948400E-01
Normal-vs-Weekly Drinker
8.850200E-01
Normal-vs-Occasional Drinker
6.648000E-01
Normal-vs-Social Drinker
5.102000E-01
Non Drinker-vs-Daily Drinker
8.866200E-01
Non Drinker-vs-Weekly Drinker
2.933700E-02
Non Drinker-vs-Occasional Drinker
2.896900E-03
Non Drinker-vs-Social Drinker
7.216500E-04
Daily Drinker-vs-Weekly Drinker
4.743800E-02
Daily Drinker-vs-Occasional Drinker
7.177500E-03
Daily Drinker-vs-Social Drinker
2.360600E-03
Weekly Drinker-vs-Occasional Drinker
6.332200E-01
Weekly Drinker-vs-Social Drinker
4.805600E-01
Occasional Drinker-vs-Social Drinker
8.283800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.720210E-01
Normal-vs-Grade 2
5.580600E-01
Normal-vs-Grade 3
5.455600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.784200E-01
Grade 1-vs-Grade 3
8.566800E-01
Grade 1-vs-Grade 4
1.720210E-01
Grade 2-vs-Grade 3
6.985200E-01
Grade 2-vs-Grade 4
5.580600E-01
Grade 3-vs-Grade 4
5.455600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.191400E-01
Normal-vs-NonDiabetic
9.251200E-01
Diabetic-vs-NonDiabetic
1.367560E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.382800E-01
Normal-vs-NoPancreatitis
7.845000E-01
Pancreatitis-vs-NoPancreatitis
9.786800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.391800E-01
Normal-vs-N1
6.780000E-01
N0-vs-N1
2.879400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.172200E-01
Normal-vs-TP53-NonMutant
9.600400E-01
TP53-Mutant-vs-TP53-NonMutant
9.035200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
